The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
915694514 9156945 14 F 20131114 20160808 20130312 20160815 EXP PHHY2012CA089789 NOVARTIS 29.31 YR F Y 0.00000 20160815 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
915694514 9156945 1 PS TASIGNA NILOTINIB 1 Oral 300 MG, BID 22068 300 MG CAPSULE BID
915694514 9156945 2 SS AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 Unknown Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
915694514 9156945 1 Chronic myeloid leukaemia
915694514 9156945 2 Lower respiratory tract infection

Outcome of event

Event ID CASEID OUTC COD
915694514 9156945 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
915694514 9156945 Appetite disorder
915694514 9156945 Arthralgia
915694514 9156945 Bone marrow disorder
915694514 9156945 Bone pain
915694514 9156945 Burning sensation
915694514 9156945 Chest pain
915694514 9156945 Dental caries
915694514 9156945 Dyspnoea
915694514 9156945 Erythema
915694514 9156945 Erythema nodosum
915694514 9156945 Facial paralysis
915694514 9156945 Fatigue
915694514 9156945 Gait disturbance
915694514 9156945 Gingival discolouration
915694514 9156945 Haemoglobin decreased
915694514 9156945 Herpes zoster
915694514 9156945 Hypersomnia
915694514 9156945 Hypoaesthesia
915694514 9156945 Joint swelling
915694514 9156945 Lower respiratory tract infection
915694514 9156945 Lymphadenopathy
915694514 9156945 Mass
915694514 9156945 Menstruation delayed
915694514 9156945 Menstruation irregular
915694514 9156945 Metrorrhagia
915694514 9156945 Middle insomnia
915694514 9156945 Mouth swelling
915694514 9156945 Oral infection
915694514 9156945 Oxygen saturation increased
915694514 9156945 Pain
915694514 9156945 Pain in extremity
915694514 9156945 Palpitations
915694514 9156945 Paraesthesia
915694514 9156945 Peripheral swelling
915694514 9156945 Pneumonia
915694514 9156945 Productive cough
915694514 9156945 Rash
915694514 9156945 Rash pruritic
915694514 9156945 Sleep terror
915694514 9156945 Swollen tongue
915694514 9156945 Tooth discolouration
915694514 9156945 White blood cell count abnormal
915694514 9156945 White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
915694514 9156945 1 20120919 0